Retaglutide is a innovative GLP-1 receptor agonist currently under study for the control of obesity. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://adrianagjri246831.howeweb.com/39666016/retaglutide-a-promising-glp-1-receptor-agonist